In this study, we examine whether the presence of a C9orf72 expansion is associated with increased risk of subsequent feature development in individuals with ALS, excluding those with SOD1-related disease lacking TDP-43 pathology, and FTD, excluding those with non-TDP-43 proteinopathy at autopsy. This evidence concerns the gene TARDBP and frontotemporal dementia.